I am NOT a scientist, but....From Waynebluechip to me: US Patient 11,045,546 granted to Cytodyn on 7/6/2021 was and is key to winning and keeping the market after first approval. Near all human sicknesses have a relationship to Hyper inflammation in the micro environment. Cytodyn patent covers it until June 25, 2040.

Me to Waynebluechip: And that is the absolute BEST part of our long term story. Unless and until someone finds a true side effect that demonstrably reduces leronlimab's desirability in treating dozens of indications, we will eventually become THE SOC for them.